Industry Overview - The cannabis industry is experiencing growth and profitability, with companies reporting positive Q1 2025 earnings despite a challenging market environment [1][2] - There is a notable disconnect between the performance of cannabis stocks and the success of legal operators, leading to speculation about potential investment opportunities [2][3] Company Highlights - **Tilray Brands, Inc.**: Engages in the research, cultivation, processing, and distribution of medical cannabis products. Recently launched a new line of cannabis beverages and gummies [4][6] - **Canopy Growth Corporation**: Focuses on the production and sale of cannabis products for recreational and medical purposes. Scheduled to release Q1 2025 financial results on May 30th [7][8] - **Cronos Group Inc.**: Involved in the cultivation and marketing of cannabis products. Reported Q1 2025 earnings on May 8th [9] Financial Performance - MAPH Enterprises reported a net revenue of $32.3 million in Q1 2025, an increase of $7.0 million from Q1 2024 - Gross profit for MAPH Enterprises reached $13.7 million in Q1 2025, up by $9.3 million from the previous year - Adjusted gross profit was $14.3 million in Q1 2025, reflecting an increase of $9.8 million from Q1 2024 - Net income for MAPH Enterprises was $7.7 million in Q1 2025, which is an increase of $10.2 million compared to Q1 2024 [11]

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis- ...